Key result
Kawasaki disease can cause early, severe coronary artery narrowing despite gammaglobulin treatment and without prominent aneurysms, remaining clinically silent until very severe.
Highlights that fatal vaso-occlusive coronary artery disease can occur early in Kawasaki disease despite standard gammaglobulin therapy and without obvious aneurysm formation.
Raises caution for occult severe stenosis in treated Kawasaki disease; leaves open optimal surveillance strategies pending larger cohorts.
In Kawasaki disease severe coronary artery narrowing may develop at an early stage despite treatment with gammaglobulin and in the absence of prominent aneurysm formation or thrombosis. Vaso-occlusive disease may not be clinically or echocardiographically apparent until very severe.
No takes yet. Share an insight, caveat, or question.
Paul Anthony Heaton (2002) studied this question. Kawasaki disease can cause early, severe coronary artery narrowing despite gammaglobulin treatment and without prominent aneurysms, remaining clinically silent until very severe.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: